CNY 34.48
(-3.88%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.38 Billion CNY | 0.49% |
2022 | 1.19 Billion CNY | 29.88% |
2021 | 912.18 Million CNY | 5.08% |
2020 | 936.21 Million CNY | -1.14% |
2019 | 972.06 Million CNY | -16.51% |
2018 | 1.06 Billion CNY | -1.05% |
2017 | 1.16 Billion CNY | 31.97% |
2016 | 810.77 Million CNY | 28.81% |
2015 | 638.64 Million CNY | 35.47% |
2014 | 471.22 Million CNY | 27.83% |
2013 | 368.84 Million CNY | 41.99% |
2012 | 258.04 Million CNY | 34.62% |
2011 | 192.63 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 215.98 Million CNY | 26.42% |
2024 Q3 | 185.29 Million CNY | -7.59% |
2024 Q2 | 164.31 Million CNY | -21.16% |
2023 Q4 | 177.42 Million CNY | -36.59% |
2023 FY | - CNY | 0.49% |
2023 Q1 | 400.78 Million CNY | 195.88% |
2023 Q2 | 379.83 Million CNY | -5.23% |
2023 Q3 | 279.81 Million CNY | -26.33% |
2022 Q4 | 135.45 Million CNY | -64.18% |
2022 Q3 | 378.1 Million CNY | 32.63% |
2022 Q2 | 285.09 Million CNY | -6.51% |
2022 Q1 | 304.95 Million CNY | 58.28% |
2022 FY | - CNY | 29.88% |
2021 Q2 | 209.54 Million CNY | 4.25% |
2021 Q3 | 250.7 Million CNY | 19.65% |
2021 Q4 | 192.66 Million CNY | -23.15% |
2021 FY | - CNY | 5.08% |
2021 Q1 | 201 Million CNY | -10.62% |
2020 Q3 | 236.87 Million CNY | 20.83% |
2020 Q4 | 224.88 Million CNY | -5.06% |
2020 FY | - CNY | -1.14% |
2020 Q1 | 159.69 Million CNY | -26.09% |
2020 Q2 | 196.04 Million CNY | 22.76% |
2019 FY | - CNY | -16.51% |
2019 Q4 | 216.06 Million CNY | -13.62% |
2019 Q3 | 250.14 Million CNY | 34.81% |
2019 Q2 | 185.55 Million CNY | -1.38% |
2019 Q1 | 188.15 Million CNY | -31.28% |
2018 Q4 | 273.81 Million CNY | -1.52% |
2018 FY | - CNY | -1.05% |
2018 Q2 | 255.2 Million CNY | 16.71% |
2018 Q1 | 218.67 Million CNY | -27.41% |
2018 Q3 | 278.02 Million CNY | 8.94% |
2017 Q2 | 206.4 Million CNY | -18.89% |
2017 Q4 | 301.22 Million CNY | 7.16% |
2017 Q3 | 281.1 Million CNY | 36.19% |
2017 Q1 | 254.47 Million CNY | 0.65% |
2017 FY | - CNY | 31.97% |
2016 Q4 | 252.82 Million CNY | 14.25% |
2016 FY | - CNY | 28.81% |
2016 Q3 | 221.29 Million CNY | 72.09% |
2016 Q2 | 128.59 Million CNY | -31.83% |
2016 Q1 | 188.62 Million CNY | -4.64% |
2015 FY | - CNY | 35.47% |
2015 Q4 | 197.81 Million CNY | 62.32% |
2015 Q3 | 121.86 Million CNY | -21.02% |
2015 Q2 | 154.29 Million CNY | -1.14% |
2015 Q1 | 156.07 Million CNY | 0.0% |
2014 FY | - CNY | 27.83% |
2013 FY | - CNY | 41.99% |
2012 FY | - CNY | 34.62% |
2011 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Liuzhou Liangmianzhen Co., Ltd. | 59.28 Million CNY | -2237.411% |
Shanghai Jahwa United Co., Ltd. | 864.85 Million CNY | -60.222% |
Henan Rebecca Hair Products Co., Ltd. | 197.77 Million CNY | -600.64% |
Perfect Group Corp., Ltd | 168.89 Million CNY | -720.442% |
RUNBEN BIOTECHNOLOGY | 290.05 Million CNY | -377.739% |
Proya Cosmetics Co.,Ltd. | 1.62 Billion CNY | 14.749% |
Lafang China Co.,Ltd | 86.16 Million CNY | -1508.104% |
Guangdong Marubi Biotechnology Co., Ltd. | 354.54 Million CNY | -290.835% |
Hangzhou Haoyue Personal Care Co., Ltd | 643.75 Million CNY | -115.252% |